Since increased cell motility and invasion are key drivers of metastasis, the methylation-induced silencing of SOX1 likely facilitates tumor dissemination, and is thus associated with poorer clinical outcomes in NSCLC patients [22]. This evidence concerns the gene SOX1 and neoplasm.